|Chemical and physical data|
|Molar mass||409.909 g/mol g·mol−1|
|3D model (JSmol)|
|NY (what is this?)|
Piclozotan (SUN-N4057) is a selective 5-HT1A receptor partial agonist, which has neuroprotective effects in animal studies. It has been through early clinical trials in humans for treatment of acute stroke, but results have not yet been announced.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|